We are live on ! Find out more
GHDX

Genomic Health, Inc.
GHDX

Delisted

GHDX was delisted on the 7th of November, 2019.

Back to rankings

134 hedge funds and large institutions have $870M invested in Genomic Health, Inc. in 2016 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 53 increasing their positions, 42 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 10

26% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 42

13% more capital invested

Capital invested by funds: $772M → $870M (+$97.6M)

3% more funds holding

Funds holding: 130 → 134 (+4)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

100% less call options, than puts

Call options by funds: $1K | Put options by funds: $220K

Holders
134
Holders Change
+4
Holders Change %
+3.08%
% of All Funds
3.57%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
14
Increased
53
Reduced
42
Closed
10
Calls
$1K
Puts
$220K
Net Calls
-$219K
Net Calls Change
+$148K

Top Buyers

Rank Fund Capital Flow
1
CWAM
Columbia Wanger Asset Management
Illinois
+$13.1M
2
EAM
Eagle Asset Management
Florida
+$8.11M
3
Charles Schwab
Charles Schwab
California
+$6.83M
4
NI
Numeric Investors
Massachusetts
+$3.18M
5
Renaissance Technologies
Renaissance Technologies
New York
+$3.11M

Top Sellers

Rank Fund Capital Flow
1
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
-$15.9M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$7.1M
3
BC
Broadfin Capital
New York
-$7M
4
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
-$6.74M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
TC
51
TFS Capital
Pennsylvania
$1.88M +$92.3K +3,313 +5%
Jacobs Levy Equity Management
52
Jacobs Levy Equity Management
New Jersey
$1.84M +$567K +20,367 +47%
Morgan Stanley
53
Morgan Stanley
New York
$1.75M -$1.24M -44,572 -42%
Wells Fargo
54
Wells Fargo
California
$1.75M -$2.37K -85 -0.1%
GCP
55
GSA Capital Partners
United Kingdom
$1.65M +$352K +12,645 +29%
Macquarie Group
56
Macquarie Group
Australia
$1.59M -$1.53M -55,000 -50%
Deutsche Bank
57
Deutsche Bank
Germany
$1.52M +$972K +34,901 +195%
CS
58
Credit Suisse
Switzerland
$1.41M +$519K +18,639 +62%
BlackRock
59
BlackRock
New York
$1.27M -$267K -9,592 -18%
Nordea Investment Management
60
Nordea Investment Management
Sweden
$1.2M +$490K +17,579 +73%
EA
61
Emerald Acquisition
Washington
$1.15M -$1.02M -36,782 -48%
California State Teachers Retirement System (CalSTRS)
62
California State Teachers Retirement System (CalSTRS)
California
$1.14M +$8.36K +300 +0.8%
Asset Management One
63
Asset Management One
Japan
$1.01M – – –
CCI
64
Columbus Circle Investors
$914K -$600K -21,546 -41%
Swiss National Bank
65
Swiss National Bank
Switzerland
$902K – – –
HI
66
HBK Investments
Texas
$894K +$6.52K +234 +0.8%
American Century Companies
67
American Century Companies
Missouri
$889K +$65.6K +2,355 +8%
PP
68
PDT Partners
New York
$867K – – –
TA
69
Teachers Advisors
New York
$867K +$3.32K +119 +0.4%
Citadel Advisors
70
Citadel Advisors
Florida
$838K +$545K +19,556 +207%
AG
71
Algert Global
California
$748K +$721K +25,877 New
CA
72
Corrado Advisors
New Jersey
$734K -$426K -15,300 -38%
SO
73
STRS Ohio
Ohio
$720K -$69.7K -2,500 -9%
AQR Capital Management
74
AQR Capital Management
Connecticut
$679K +$364K +13,062 +125%
ProShare Advisors
75
ProShare Advisors
Maryland
$662K -$111K -3,975 -15%
1 2
3
4 5

GHDX Hedge Fund Activity: Q3 2016 in Review

134 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Genomic Health, Inc. (GHDX) for Q3 2016, worth a combined $870M — up 13% from $772M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new GHDX positions and 10 closed out — a net gain of 4 holders — while 53 added to existing stakes and 42 trimmed.

The largest buyer was Columbia Wanger Asset Management, opening a new position worth an estimated $13.1M. The largest seller was Baillie Gifford & Co, cutting an estimated $15.9M.

  • 134 institutional investors held Genomic Health, Inc. (GHDX) as of Q3 2016, up from 130 in Q2 2016.
  • Funds reported $870M of Genomic Health, Inc. stock for Q3 2016, up 13% quarter-over-quarter.
  • 14 funds opened new Genomic Health, Inc. positions in Q3 2016 and 10 closed out, a net change of +4 holders.
  • The largest Genomic Health, Inc. buyer in Q3 2016 was Columbia Wanger Asset Management, an estimated $13.1M added.
  • The largest Genomic Health, Inc. seller in Q3 2016 was Baillie Gifford & Co, an estimated $15.9M sold.

Based on aggregated 13F filings for Q3 2016.